These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25744200)

  • 1. The impact of reliable prebolus T 1 measurements or a fixed T 1 value in the assessment of glioma patients with dynamic contrast enhancing MRI.
    Tietze A; Mouridsen K; Mikkelsen IK
    Neuroradiology; 2015 Jun; 57(6):561-72. PubMed ID: 25744200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
    Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
    Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of B
    Sengupta A; Gupta RK; Singh A
    J Transl Med; 2017 Dec; 15(1):242. PubMed ID: 29197390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas.
    Nguyen TB; Cron GO; Mercier JF; Foottit C; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Caudrelier JM; Sinclair J; Hogan MJ; Thornhill RE; Cameron IG
    AJNR Am J Neuroradiol; 2012 Sep; 33(8):1539-45. PubMed ID: 22442046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
    Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
    Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
    Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
    J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
    Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
    J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
    Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI.
    Larsson C; Kleppestø M; Grothe I; Vardal J; Bjørnerud A
    J Magn Reson Imaging; 2015 Jul; 42(1):97-104. PubMed ID: 25350816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.